Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 16-Sep-24
Select bar for recommendation details.
Recommendations | 16-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 5 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Terns Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 30.00 and a low estimate of 5.50. The median estimate represents a 89.24% increase from the last price of 10.04.
High | 198.8% | 30.00 |
Med | 89.2% | 19.00 |
Low | -45.2% | 5.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | -10.96% |
Average growth rate | +48.67% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -50.00% |
More ▼